2012
DOI: 10.1007/s10910-012-0047-1
|View full text |Cite
|
Sign up to set email alerts
|

A meta-analysis of studies using MR spectroscopy for evaluating suspicious lesions after radiation therapy of primary brain tumors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 39 publications
0
4
0
Order By: Relevance
“…While most works screen for all the main proton MRS molecules, 36,37,[39][40][41] some choose to focus on specific frequency ranges. 38 We…”
Section: Discussionmentioning
confidence: 99%
“…While most works screen for all the main proton MRS molecules, 36,37,[39][40][41] some choose to focus on specific frequency ranges. 38 We…”
Section: Discussionmentioning
confidence: 99%
“…Magnetic resonance spectroscopy and MRSI are now among the key modalities for nearly all aspects of brain tumor diagnostics and management for both the adult and pediatric populations. This includes initial diagnosis [82], tumor characterization [85] and grading [88], treatment planning in RT [89], surgical guidance [90], as well post-therapeutic follow-up [91][92][93].…”
Section: Primary Brain Tumorsmentioning
confidence: 99%
“…A notable example is that recurrent primary brain tumors are quite often misclassified as radiation necrosis, and vice verse, according to meta-analysis from Refs. [91][92][93]. Another example of great importance for PCM is to distinguish non-tumorous cerebral hypoxia/ischemia from brain tumors.…”
Section: Primary Brain Tumorsmentioning
confidence: 99%
“…Namely, within the FFT neuro-diagnostics through MRS/MRSI have often been reduced to semi-quantitative approaches based upon a very small number of metabolites and/or their ratios. Within radiation neuro-oncology, our recent meta-analysis (39) revealed that by using metabolite ratios, a substantial percentage of recurrent primary brain tumors and radiation necrosis were misclassified. The FPT applied to in vitro MRS time signals encoded from normal human brain achieves markedly superior resolution compared to the FFT, and can identify and precisely quantify at least 25 metabolites (16)(17)(18)40).…”
Section: Neuro-oncologymentioning
confidence: 99%